Metropolitan Life Insurance Company (MetLife)’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-4,963
| Closed | -$678K | – | 2670 |
|
|
2018
Q2 | $678K | Buy |
4,963
+559
| +13% | +$50.8K | 0.01% | 1117 |
|
|
2018
Q1 | $347K | Sell |
4,404
-740
| -14% | -$54.6K | ﹤0.01% | 1512 |
|
|
2017
Q4 | $351K | Sell |
5,144
-5,347
| -51% | -$277K | ﹤0.01% | 1521 |
|
|
2017
Q3 | $422K | Hold |
10,491
| – | – | ﹤0.01% | 1802 |
|
|
2017
Q2 | $417K | Buy |
10,491
+221
| +2% | +$8.09K | ﹤0.01% | 1834 |
|
|
2017
Q1 | $331K | Sell |
10,270
-628
| -6% | -$15.7K | ﹤0.01% | 1942 |
|
|
2016
Q4 | $193K | Buy |
10,898
+583
| +6% | +$12.6K | ﹤0.01% | 2370 |
|
|
2016
Q3 | $241K | Hold |
10,315
| – | – | ﹤0.01% | 2227 |
|
|
2016
Q2 | $192K | Hold |
10,315
| – | – | ﹤0.01% | 2343 |
|
|
2016
Q1 | $188K | Hold |
10,315
| – | – | ﹤0.01% | 2214 |
|
|
2015
Q4 | $217K | Hold |
10,315
| – | – | ﹤0.01% | 2217 |
|
|
2015
Q3 | $190K | Hold |
10,315
| – | – | ﹤0.01% | 2317 |
|
|
2015
Q2 | $349K | Buy |
+10,315
| New | +$415K | ﹤0.01% | 2013 |
|
|
2015
Q1 | – | Sell |
-11,239
| Closed | -$250K | – | 2564 |
|
|
2014
Q4 | $250K | Hold |
11,239
| – | – | ﹤0.01% | 2248 |
|
|
2014
Q3 | $213K | Hold |
11,239
| – | – | ﹤0.01% | 2327 |
|
|
2014
Q2 | $303K | Buy |
11,239
+5,033
| +81% | +$128K | ﹤0.01% | 2197 |
|
|
2014
Q1 | $201K | Buy |
+6,206
| New | +$202K | ﹤0.01% | 2458 |
|
Metropolitan Life Insurance Company (MetLife)'s FMI Position: Q3 2018 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 4,963 shares — an estimated $678K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in FMI in Q1 2014 and held it in 17 quarters. The position peaked at $678K in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 4,963 Foundation Medicine, Inc. shares in Q3 2018, an estimated $678K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Foundation Medicine, Inc. in Q1 2014 and held it in 17 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Foundation Medicine, Inc. position peaked at $678K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2018, filed 14 Nov 2018.